A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J.
Schmidt-Kraepelin C, et al.
Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):83-94. doi: 10.1007/s00406-019-01063-4. Epub 2019 Sep 5.
Eur Arch Psychiatry Clin Neurosci. 2020.
PMID: 31486890